WHO Chemical Risk Assessment Workshop on new and emerging risks to human health from chemicals RIVM is hosting an international workshop on new and emerging risks from chemicals on 20 and 21 February 2019.
Possible health risks due to exposure to chromium-6 at tROM project Tilburg Research by RIVM shows that the participants in the so-called tROM project, their supervisors and other people involved may have been exposed to chromium-6.
Kick off European Project VITAL: Vaccines and InfecTious diseases in the Ageing popuLation Recently, the EU-sponsored Vaccines and InfecTious diseases in the Ageing popuLation (VITAL) project was launched.
Application of personalised medicine: opportunities and challenges Pharmacotherapy based on individual patient characteristics such as genetic makeup, offers many potential benefits towards more effective treatment of a patients’ disease.
Strict diet combats aging diseases Mice with a severe aging disease live three times longer if they eat thirty percent less. Moreover, they age much healthier than mice that eat as much as they want.
Improved protection against pertussis The international PERISCOPE project has been granted a 30 million Euro European subsidy in order to better map the immune response to pertussis infection and vaccination.
Less STI tests in The Netherlands The number of people who were tested for a Sexually Transmitted Infection (STI) at a Dutch STI clinic has dropped for the first time in years.
RIVM and Chinese monitoring center for oceans exploring collaboration Knowledge development in China is valuable for addressing environmental issues in Europe, and vice versa.
Technical files of silicone breast implants show shortcomings For medical devices such as breast implants, manufacturers are obliged to compile a ‘technical file’ based on which market authorization of the product will be decided.
Annual report 2015 RIVM online In our annual report, we look back at compelling RIVM projects and research in 2015.